Cancer

Global Spending on Cancer Drugs has Doubled in Five Years

Cancer Drugs Spending

According to a new report, global costs on cancer drugs spending has doubled over the past five years. The IQVIA Institute for Human Data Science (previously known as IMS Health and Quintiles) states that the average cost of a new cancer drug released in 2017 was $150,000 and unfortunately, these prices are expected to double again by 2022.

Frequently Asked Questions

What is the main topic discussed in this episode of Health Professional Radio?

This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.

How can healthcare professionals benefit from this information?

Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.

Where can I find more information about Cancer?

For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.

From $96 billion in 2013, global spending on cancer drugs rose to $133 billion in 2017. Drugs to treat lung cancer, breast cancer, ovarian cancer and some types of leukemia were among those launched in 2017, which mostly came in the form of pills.

In the US, cancer is now the the second most common cause of death and according to the American Cancer Society, around 1.7 million people will be diagnosed with cancer in 2018. Out of those 1.7 million people, 609,000 will die as a result of it.

Last updated: January 22, 2019

Medical Disclaimer

The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.